lumbar
-
Spine
Centinel Spine® Announces Record Revenue and Growth in 2022, Achieving Number Two Market Position in Cervical and Lumbar Total Disc Replacement
Full year 2022 Motion Preservation record revenue was approximately $45 million, achieving the number two total disc replacement (TDR) market position…
Read More » -
Spine
Dr. Anton Jorgensen begins lumbar total Joint replacement clinical trial in San Antonio, TX with 3Spine, Inc.
Anton Jorgensen, MD SAN ANTONIO, March 6, 2023 –PRNewswire — Anton Jorgensen, MD and Ortho San Antonio announced today the first cases in the…
Read More » -
Spine
Aetna® Updates Disc Replacement Guidelines; All Major Payors Now Cover Centinel Spine’s Lumbar Total Disc Replacement
Updated medical necessity guidelines by Aetna® now cover one-level Lumbar Total Disc Replacement (TDR).Aetna is one of the largest commercial…
Read More » -
Spine
DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease
Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of…
Read More » -
Spine
New CPT Code Now Effective for Second Level of Lumbar Total Disc Replacement Procedures
The American Medical Association has issued a new CPT® add-on code for the second level of lumbar total disc replacement (TDR)…
Read More » -
Spine
VySpine Announces FDA Clearance for LumiVy Lumbar IBF with NanoVy Ti
Tallahassee, FL – January 17, 2023 /OrthoSpineNews/—VySpine, a spine innovation leader using differentiated materials and designs, announced today that it…
Read More » -
Spine
Orthofix Announces Publication of Data Demonstrating the Clinical Benefits of Trinity Elite Cellular Bone Allograft in Lumbar Fusion Procedures
LEWISVILLE, TEXAS, December 22, 2022 –(BUSINESS WIRE)– Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Spine
ChoiceSpine™ Announces Line Extension of their Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System
November 22, 2022 KNOXVILLE, Tenn.–(BUSINESS WIRE)–ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of…
Read More » -
Spine
Spinal Stabilization Technologies Ltd. Announces Start of LOPAIN 2 Clinical Trial in South America for Lumbar Degenerative Disc Disease
KILKENNY, Ireland, Nov. 16, 2022 /OrthoSpineNews/ — Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™…
Read More » -
Spine
DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa
SALT LAKE CITY, Oct. 5, 2022 /PRNewswire/ — DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate…
Read More » -
Spine
Wenzel Spine Announces the Launch of the S-LIF Procedure: Prioritizing Surgical Minimalism for Outpatient Spine Fusion
August 29, 2022 AUSTIN, Texas–(OrthoSpineNews)–Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive surgical and diagnostic solutions…
Read More » -
Spine
Nexus Spine Announces Full Commercial Launch of PressON™ Posterior Lumbar Fixation System
Unique elastic interference technology solves set screw loosening and eliminates rod bending August 23, 2022 SALT LAKE CITY–(BUSINESS WIRE)–Nexus Spine,…
Read More » -
Spine
AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial
On August 8, 2022, AxioMed LLC submitted to the FDA all the required documents for Module III. This is the…
Read More » -
Spine
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumbar Interbody System Featuring Reef ™ A Interbody
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
First Patient Enrollment Milestone Completed MELVILLE, NY., June 30, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:…
Read More »